VBI Vaccines Announces Poster Presentation at 2024 ASCO Annual Meeting Highlighting New Interim Phase 2b Data from VBI-1901 in Recurrent Glioblastoma Patients
Stock Information for VBI Vaccines Inc.
Loading
Please wait while we load your information from QuoteMedia.